Retreatment Rate Discrepancy

The percentage of children requiring second and third courses of treatment differs across three authoritative TLC sources:

These are not minor rounding differences. The variation from 75% to 85% for second-course retreatment represents a 10-percentage-point spread — a substantial discrepancy for a key outcome measure in a rigorous clinical trial.

The most obvious explanation would be that the 1998 paper reported interim data while later publications used final enrollment figures. However, this explanation does not hold.

Key timeline facts:

• TLC enrollment was completed by January 1997
• The Design & Recruitment paper (reporting 75%/81%) was published in November 1998
• The paper was submitted well after enrollment closed

By November 1998, all 780 children had been enrolled, randomized, and completed their treatment courses. The Design & Recruitment paper should have reflected final retreatment data, yet it reports substantially lower rates than the 2001 NEJM paper and the NIEHS website.

If the 1998 paper was based on incomplete data, this should have been noted. If the 2001 paper corrected an earlier error, this should have been acknowledged. Neither publication addresses the discrepancy.

A 10-percentage-point variation in retreatment rates across official TLC publications raises questions about data management and quality assurance:

• Data entry errors: Different database queries or extraction methods could have produced different counts
• Definition drift: The criteria for “requiring” retreatment may have been applied inconsistently
• Lack of reconciliation: Publications were not cross-checked against a single source of truth
• No errata published: If errors were discovered, corrections were not made to the literature

In isolation, this discrepancy might be a minor clerical issue. In the context of other TLC data concerns — such as the missing MEMS adherence data, the unpublished stratified iron analyses, and the unreported site-by-treatment interactions — it contributes to a broader pattern of incomplete or inconsistent reporting.

Retreatment rates are not incidental data. They reflect a core outcome: how many children’s blood lead levels remained above 15 µg/dL despite chelation therapy.

High retreatment rates (75–85%) indicate that chelation was not achieving sustained blood lead reduction — children were being re-exposed faster than the drug could clear lead from their systems. This is consistent with the environmental exposure problem documented elsewhere: children were being chelated in contaminated homes without remediation.

The exact retreatment percentage matters for understanding treatment efficacy. A 75% retreatment rate tells a different story than 85%. The fact that three official sources report three different numbers undermines confidence in TLC’s data integrity.

No public explanation for this discrepancy has been offered. The original data are not available for independent verification.